Ticker
EDITCompany Name
EDITAS MEDICINE INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 38.9M | $ 14.46M | 37.18% |
3/31/2025 | $ 35.84M | $ 16.81M | 46.91% |
12/31/2024 | $ 32.31M | $ 21.42M | 66.28% |
9/30/2024 | $ 61.76M | $ 22.74M | 36.82% |
6/30/2024 | $ 67.03M | $ 22.67M | 33.82% |
3/31/2024 | $ 69.41M | $ 22.88M | 32.96% |
12/31/2023 | $ 78.12M | $ 19.8M | 25.34% |
9/30/2023 | $ 24.61M | $ 19.82M | 80.52% |
6/30/2023 | $ 19.32M | $ 20.97M | 108.55% |
3/31/2023 | $ 22.79M | $ 22.37M | 98.15% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for EDITAS MEDICINE INC is calculated as follows: SB Comp. [ $ 23.82M ] / Revenues [ $ 91.6M ]
(=) SB Comp % [ 26% ]
Minimum
Dec 31, 2023
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 2.99K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |